Concepedia

Virginie Sippel

VS

Statistics

Publications

4

Citations

251

H-Index

4

Active since

2010

Affiliations

Actelion (Switzerland)(Current)

Idorsia (Switzerland)

Virginie Sippel is an author at Actelion (Switzerland) specializing in sphingosine 1-phosphate signaling, autoimmunity, and immunology.

ORCID

Publications per year

2010–2023

4

Publications

4

2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub>Receptor Agonists

Martin H. Bolli, Stefan Abele, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2010 · 178 citations · Full text

, , +17

Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity

Jean‐Philippe Surivet, Roland Lange, Christian Hubschwerlen et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

, , +15

Preclinical to clinical translation of cenerimod, a novel S1P<sub>1</sub> receptor modulator, in systemic lupus erythematosus

Daniel S. Strasser, Sylvie Froidevaux, Virginie Sippel et al. · RMD Open · 2020 · 22 citations · Full text

, , +17

Pharmacokinetics, pharmacodynamics and safety of the novel C‐X‐C chemokine receptor 3 antagonist ACT‐777991: Results from the first‐in‐human study in healthy adults

Marie‐Laure Boof, Martine Géhin, Christine Voors‐Pette et al. · British Journal of Clinical Pharmacology · 2023 · 16 citations · Full text

, , +14

1–4 of 4